{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:25:30Z","timestamp":1760243130880,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303366\/2015-0 and 406696\/2021-7"],"award-info":[{"award-number":["303366\/2015-0 and 406696\/2021-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/15402-2, 2016\/26209-1, and 2017\/03708-5"],"award-info":[{"award-number":["2015\/15402-2, 2016\/26209-1, and 2017\/03708-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15489-5","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T10:11:03Z","timestamp":1754907063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the myocardial effects of Bradykinin inhibitors by cardiac magnetic resonance (CMR) in discharged COVID-19 patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Adriana Aparecida","family":"Bau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduarda O. Z.","family":"Minin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Miguel","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layde Rosane","family":"Paim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Nicolela Geraldo","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Coy-Cangu\u00e7u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Dantas Tavares","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Dertkigil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Roberto","family":"Matos-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Nadruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Bombassaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edcio A.","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jerosch-Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ot\u00e1vio Rizzi","family":"Coelho-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"15489_CR1","doi-asserted-by":"publisher","first-page":"7423537","DOI":"10.1155\/2022\/7423537","volume":"2022","author":"A Tabassum","year":"2022","unstructured":"Tabassum, A. et al. Dysregulated bradykinin: mystery in the pathogenesis of COVID-19. Mediators Inflamm. 2022, 7423537. https:\/\/doi.org\/10.1155\/2022\/7423537 (2022).","journal-title":"Mediators Inflamm."},{"key":"15489_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13063-021-05027-9","volume":"22","author":"E Mansour","year":"2021","unstructured":"Mansour, E. et al. Evaluation of the efficacy and safety of Icatibant and C1 esterase\/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial. Trials 22, 71. https:\/\/doi.org\/10.1186\/s13063-021-05027-9 (2021).","journal-title":"Trials"},{"key":"15489_CR3","doi-asserted-by":"publisher","unstructured":"Mansour, E. et al. Safety and outcomes associated with the Pharmacological Inhibition of the Kinin-Kallikrein system in severe COVID-19. Viruses 13 https:\/\/doi.org\/10.3390\/v13020309 (2021).","DOI":"10.3390\/v13020309"},{"key":"15489_CR4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann, V. O. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 1265\u20131273. https:\/\/doi.org\/10.1001\/jamacardio.2020.3557 (2020).","journal-title":"JAMA Cardiol."},{"key":"15489_CR5","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/jmv.26496","volume":"93","author":"M Arafkas","year":"2021","unstructured":"Arafkas, M. et al. Current meta-analysis does not support the possibility of COVID-19 reinfections. J. Med. Virol. 93, 1599\u20131604. https:\/\/doi.org\/10.1002\/jmv.26496 (2021).","journal-title":"J. Med. Virol."},{"key":"15489_CR6","doi-asserted-by":"publisher","first-page":"e027801","DOI":"10.1161\/JAHA.122.027801","volume":"12","author":"M Jerosch-Herold","year":"2023","unstructured":"Jerosch-Herold, M., Rickers, C., Petersen, S. E. & Coelho-Filho, O. R. Myocardial tissue characterization in cardiac magnetic resonance studies of patients recovering from COVID-19: A Meta-Analysis. J. Am. Heart Assoc. 12, e027801. https:\/\/doi.org\/10.1161\/JAHA.122.027801 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"15489_CR7","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik, T. J. et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 116, 1666\u20131687. https:\/\/doi.org\/10.1093\/cvr\/cvaa106 (2020).","journal-title":"Cardiovasc. Res."},{"key":"15489_CR8","doi-asserted-by":"publisher","unstructured":"Fijalkowska, J. et al. Cardiac magnetic resonance relaxometry parameters, late gadolinium enhancement, and Feature-Tracking myocardial longitudinal strain in patients recovered from COVID-19. J. Cardiovasc. Dev. Dis. 10 https:\/\/doi.org\/10.3390\/jcdd10070278 (2023).","DOI":"10.3390\/jcdd10070278"},{"key":"15489_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.cir.95.3.701","volume":"95","author":"G Horstick","year":"1997","unstructured":"Horstick, G. et al. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 95, 701\u2013708. https:\/\/doi.org\/10.1161\/01.cir.95.3.701 (1997).","journal-title":"Circulation"},{"key":"15489_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/01.cir.91.2.393","volume":"91","author":"M Buerke","year":"1995","unstructured":"Buerke, M., Murohara, T. & Lefer, A. M. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91, 393\u2013402. https:\/\/doi.org\/10.1161\/01.cir.91.2.393 (1995).","journal-title":"Circulation"},{"key":"15489_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0161-5890(99)00048-6","volume":"36","author":"M Kirschfink","year":"1999","unstructured":"Kirschfink, M. & Nurnberger, W. C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application. Mol. Immunol. 36, 225\u2013232. https:\/\/doi.org\/10.1016\/s0161-5890(99)00048-6 (1999).","journal-title":"Mol. Immunol."},{"key":"15489_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jcmg.2018.05.012","volume":"11","author":"T Ferreira de Souza","year":"2018","unstructured":"Ferreira de Souza, T. et al. Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease. JACC Cardiovasc. Imaging. 11, 1045\u20131055. https:\/\/doi.org\/10.1016\/j.jcmg.2018.05.012 (2018).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"15489_CR13","doi-asserted-by":"publisher","first-page":"880151","DOI":"10.3389\/fcvm.2022.880151","volume":"9","author":"C Nardi Gemme","year":"2022","unstructured":"Nardi Gemme, C. et al. Diffuse myocardial fibrosis and cardiomyocyte diameter are associated with heart failure symptoms in Chagas cardiomyopathy. Front. Cardiovasc. Med. 9, 880151. https:\/\/doi.org\/10.3389\/fcvm.2022.880151 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"15489_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.112.000438","volume":"128","author":"OR Coelho-Filho","year":"2013","unstructured":"Coelho-Filho, O. R. et al. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation 128, 1225\u20131233. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000438 (2013).","journal-title":"Circulation"},{"key":"15489_CR15","doi-asserted-by":"publisher","first-page":"e000279","DOI":"10.1161\/JAHA.113.000279","volume":"2","author":"RV Shah","year":"2013","unstructured":"Shah, R. V. et al. Myocardial tissue remodeling in adolescent obesity. J. Am. Heart Assoc. 2, e000279. https:\/\/doi.org\/10.1161\/JAHA.113.000279 (2013).","journal-title":"J. Am. Heart Assoc."},{"key":"15489_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/CIRCIMAGING.112.979815","volume":"6","author":"OR Coelho-Filho","year":"2013","unstructured":"Coelho-Filho, O. R. et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ. Cardiovasc. Imaging. 6, 134\u2013141. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.979815 (2013).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"15489_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/01.hyp.35.1.391","volume":"35","author":"P Madeddu","year":"2000","unstructured":"Madeddu, P. et al. Angiotensin II type 1 receptor Blockade prevents cardiac remodeling in Bradykinin B(2) receptor knockout mice. Hypertension 35, 391\u2013396. https:\/\/doi.org\/10.1161\/01.hyp.35.1.391 (2000).","journal-title":"Hypertension"},{"key":"15489_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.lfs.2010.10.011","volume":"87","author":"D Roman-Campos","year":"2010","unstructured":"Roman-Campos, D. et al. Investigation of the cardiomyocyte dysfunction in Bradykinin type 2 receptor knockout mice. Life Sci. 87, 715\u2013723. https:\/\/doi.org\/10.1016\/j.lfs.2010.10.011 (2010).","journal-title":"Life Sci."},{"key":"15489_CR19","doi-asserted-by":"publisher","first-page":"106304","DOI":"10.1016\/j.intimp.2020.106304","volume":"82","author":"MA Wu","year":"2020","unstructured":"Wu, M. A. et al. The central role of endothelium in hereditary angioedema due to C1 inhibitor deficiency. Int. Immunopharmacol. 82, 106304. https:\/\/doi.org\/10.1016\/j.intimp.2020.106304 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"15489_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bbrc.2006.08.065","volume":"349","author":"J Fu","year":"2006","unstructured":"Fu, J. et al. Anti-apoptotic role for C1 inhibitor in ischemia\/reperfusion-induced myocardial cell injury. Biochem. Biophys. Res. Commun. 349, 504\u2013512. https:\/\/doi.org\/10.1016\/j.bbrc.2006.08.065 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"15489_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1056\/NEJMoa0906393","volume":"363","author":"M Cicardi","year":"2010","unstructured":"Cicardi, M. et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl. J. Med. 363, 532\u2013541. https:\/\/doi.org\/10.1056\/NEJMoa0906393 (2010).","journal-title":"N Engl. J. Med."},{"key":"15489_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cardiores.2006.10.014","volume":"73","author":"HJ Li","year":"2007","unstructured":"Li, H. J. et al. Tissue Kallikrein protects against pressure overload-induced cardiac hypertrophy through Kinin B2 receptor and glycogen synthase kinase-3beta activation. Cardiovasc. Res. 73, 130\u2013142. https:\/\/doi.org\/10.1016\/j.cardiores.2006.10.014 (2007).","journal-title":"Cardiovasc. Res."},{"key":"15489_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cvr\/cvn223","volume":"80","author":"YY Yao","year":"2008","unstructured":"Yao, Y. Y. et al. Tissue Kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Cardiovasc. Res. 80, 354\u2013364. https:\/\/doi.org\/10.1093\/cvr\/cvn223 (2008).","journal-title":"Cardiovasc. Res."},{"key":"15489_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1398-9995.2011.02751.x","volume":"67","author":"M Cicardi","year":"2012","unstructured":"Cicardi, M. et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an international working group. Allergy 67, 147\u2013157. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02751.x (2012).","journal-title":"Allergy"},{"key":"15489_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/imr.12469","volume":"274","author":"B Ghebrehiwet","year":"2016","unstructured":"Ghebrehiwet, B., Kaplan, A. P., Joseph, K. & Peerschke, E. I. The complement and contact activation systems: partnership in pathogenesis beyond angioedema. Immunol. Rev. 274, 281\u2013289. https:\/\/doi.org\/10.1111\/imr.12469 (2016).","journal-title":"Immunol. Rev."},{"key":"15489_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12016-021-08851-8","volume":"60","author":"ML Debreczeni","year":"2021","unstructured":"Debreczeni, M. L., Nemeth, Z., Kajdacsi, E., Farkas, H. & Cervenak, L. Molecular dambusters: what is behind hyperpermeability in Bradykinin-Mediated angioedema?? Clin. Rev. Allergy Immunol. 60, 318\u2013347. https:\/\/doi.org\/10.1007\/s12016-021-08851-8 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"15489_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12016-021-08842-9","volume":"60","author":"AL Ferrara","year":"2021","unstructured":"Ferrara, A. L. et al. Roles of immune cells in hereditary angioedema. Clin. Rev. Allergy Immunol. 60, 369\u2013382. https:\/\/doi.org\/10.1007\/s12016-021-08842-9 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"15489_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jcmg.2021.08.021","volume":"15","author":"SE Petersen","year":"2022","unstructured":"Petersen, S. E. et al. Cardiovascular magnetic resonance for patients with COVID-19. JACC Cardiovasc. Imaging. 15, 685\u2013699. https:\/\/doi.org\/10.1016\/j.jcmg.2021.08.021 (2022).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"15489_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12968-023-00933-0","volume":"25","author":"VM Ferreira","year":"2023","unstructured":"Ferreira, V. M. et al. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the society for cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 25, 21. https:\/\/doi.org\/10.1186\/s12968-023-00933-0 (2023).","journal-title":"J. Cardiovasc. Magn. Reson."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15489-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15489-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15489-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:02:11Z","timestamp":1760144531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15489-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15489"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15489-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: Marcelo Dantas Tavares de Melo and Sergio Dertkigil were incorrectly affiliated. The correct Information now accompanies the original Article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the State University of Campinas reviewed and approved the studies involving human participants. The CAEE protocol is 32076720.9.0000.5404. The patients\/participants provided written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"29340"}}